One-year outcome of bilateral randomised prospective clinical trial comparing photorefractive keratectomy (PRK) with mitomycin C (MMC) and laser in situ keratomileusis (LASIK)
One-year outcome of bilateral randomised prospective clinical trial comparing photorefractive keratectomy (PRK) with mitomycin C (MMC) and laser in situ keratomileusis (LASIK)